Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study

Detalhes bibliográficos
Autor(a) principal: Gabriel Macedo Costa Guimarães
Data de Publicação: 2023
Outros Autores: Renan Faustino, Any Caroline Oliveira, Lilian Santos Alves, Fabiana Rabe Carvalho, Katia Lino Baptista, Hugo Henrique Kegler dos Santos, Jorge Reis Almeida, Thalia Medeiros, Andrea Alice Silva
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/213237
Resumo: This study aimed to evaluate the hematological and coagulation parameters according to the clinical outcomes of coronavirus disease (COVID-19). We analyzed the hematological and coagulation parameters of hospitalized patients with COVID-19 at admission, and two and three weeks during hospitalization. To assess the performance of these parameters in predicting poor outcomes, receiver operating characteristic (ROC) curves were created. We studied 128 patients with COVID-19 (59.2±17.7 years, 56% male). Non-survivors (n=54, 42%) presented significant alterations in hematological and coagulation parameters at admission, such as increased in white blood cells (WBC), neutrophil, and band cell counts, as well as elevated prothrombin time (PT), activated partial thromboplastin time, and D-dimer levels. During follow-up, the same group presented a gradual increase in D-dimer and PT levels, accompanied by a reduction in PT activity, hemoglobin, and red blood cell count (RBC). ROC curves showed that WBC, neutrophil, and band cell counts presented the best area under the curve (AUC) values with sensitivity and specificity of >70%; however, a logistic regression model combining all the parameters, except for RBC, presented an AUC of 0.89, sensitivity of 84.84%, and specificity of 77.41%. Our study shows that significant alterations in hematological and coagulation tests at admission could be useful predictors of disease severity and mortality in COVID-19.
id USP-31_15e588026d2de5f35cd21ecbc41d474e
oai_identifier_str oai:revistas.usp.br:article/213237
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up studyCOVID-19HematologyCoagulationPredictorsDeathThis study aimed to evaluate the hematological and coagulation parameters according to the clinical outcomes of coronavirus disease (COVID-19). We analyzed the hematological and coagulation parameters of hospitalized patients with COVID-19 at admission, and two and three weeks during hospitalization. To assess the performance of these parameters in predicting poor outcomes, receiver operating characteristic (ROC) curves were created. We studied 128 patients with COVID-19 (59.2±17.7 years, 56% male). Non-survivors (n=54, 42%) presented significant alterations in hematological and coagulation parameters at admission, such as increased in white blood cells (WBC), neutrophil, and band cell counts, as well as elevated prothrombin time (PT), activated partial thromboplastin time, and D-dimer levels. During follow-up, the same group presented a gradual increase in D-dimer and PT levels, accompanied by a reduction in PT activity, hemoglobin, and red blood cell count (RBC). ROC curves showed that WBC, neutrophil, and band cell counts presented the best area under the curve (AUC) values with sensitivity and specificity of >70%; however, a logistic regression model combining all the parameters, except for RBC, presented an AUC of 0.89, sensitivity of 84.84%, and specificity of 77.41%. Our study shows that significant alterations in hematological and coagulation tests at admission could be useful predictors of disease severity and mortality in COVID-19.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-05-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21323710.1590/s2175-97902023e21798Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21798Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21798Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e217982175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/213237/195212https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessGabriel Macedo Costa GuimarãesRenan FaustinoAny Caroline OliveiraLilian Santos AlvesFabiana Rabe CarvalhoKatia Lino BaptistaHugo Henrique Kegler dos SantosJorge Reis AlmeidaThalia MedeirosAndrea Alice Silva2023-06-16T19:49:32Zoai:revistas.usp.br:article/213237Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-06-16T19:49:32Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
title Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
spellingShingle Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
Gabriel Macedo Costa Guimarães
COVID-19
Hematology
Coagulation
Predictors
Death
title_short Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
title_full Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
title_fullStr Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
title_full_unstemmed Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
title_sort Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study
author Gabriel Macedo Costa Guimarães
author_facet Gabriel Macedo Costa Guimarães
Renan Faustino
Any Caroline Oliveira
Lilian Santos Alves
Fabiana Rabe Carvalho
Katia Lino Baptista
Hugo Henrique Kegler dos Santos
Jorge Reis Almeida
Thalia Medeiros
Andrea Alice Silva
author_role author
author2 Renan Faustino
Any Caroline Oliveira
Lilian Santos Alves
Fabiana Rabe Carvalho
Katia Lino Baptista
Hugo Henrique Kegler dos Santos
Jorge Reis Almeida
Thalia Medeiros
Andrea Alice Silva
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gabriel Macedo Costa Guimarães
Renan Faustino
Any Caroline Oliveira
Lilian Santos Alves
Fabiana Rabe Carvalho
Katia Lino Baptista
Hugo Henrique Kegler dos Santos
Jorge Reis Almeida
Thalia Medeiros
Andrea Alice Silva
dc.subject.por.fl_str_mv COVID-19
Hematology
Coagulation
Predictors
Death
topic COVID-19
Hematology
Coagulation
Predictors
Death
description This study aimed to evaluate the hematological and coagulation parameters according to the clinical outcomes of coronavirus disease (COVID-19). We analyzed the hematological and coagulation parameters of hospitalized patients with COVID-19 at admission, and two and three weeks during hospitalization. To assess the performance of these parameters in predicting poor outcomes, receiver operating characteristic (ROC) curves were created. We studied 128 patients with COVID-19 (59.2±17.7 years, 56% male). Non-survivors (n=54, 42%) presented significant alterations in hematological and coagulation parameters at admission, such as increased in white blood cells (WBC), neutrophil, and band cell counts, as well as elevated prothrombin time (PT), activated partial thromboplastin time, and D-dimer levels. During follow-up, the same group presented a gradual increase in D-dimer and PT levels, accompanied by a reduction in PT activity, hemoglobin, and red blood cell count (RBC). ROC curves showed that WBC, neutrophil, and band cell counts presented the best area under the curve (AUC) values with sensitivity and specificity of >70%; however, a logistic regression model combining all the parameters, except for RBC, presented an AUC of 0.89, sensitivity of 84.84%, and specificity of 77.41%. Our study shows that significant alterations in hematological and coagulation tests at admission could be useful predictors of disease severity and mortality in COVID-19.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/213237
10.1590/s2175-97902023e21798
url https://www.revistas.usp.br/bjps/article/view/213237
identifier_str_mv 10.1590/s2175-97902023e21798
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/213237/195212
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21798
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21798
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21798
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918143115264